Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OSU6162 as add-on in SSRI/SNRI-resistant Depression (ODEN): a Double-blind, Placebo-controlled Evaluation of Efficacy and Safety

NCT05641623 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT05641623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05641623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OSU6162 as add-on in SSRI/SNRI-resistant Depression (ODEN): a Double-blind, Placebo-controlled Evaluation of Efficacy and Safety
Lead sponsor
Göteborg University
Phase
Phase 2
Overall status
Recruiting
Start date
April 21, 2022
Completion date
December 31, 2029
Enrollment
180 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depressive disorder, depressive disorder, treatment-resistant, depressive episode, recurrent depression, recurrent depressive disorder